Abstract：
UNASSIGNED: A symptomatic os trigonum is a common cause of posterior ankle pain that has been traditionally managed with open excision. Minimally invasive surgery (MIS) has been proposed as an alternative to open excision for improved outcomes and decreased complication rates; however, no systematic review to date has examined the utilization of MIS for a symptomatic os trigonum.
UNASSIGNED: To examine patient outcomes, return to sport, and complications associated with MIS for a symptomatic os trigonum.
UNASSIGNED: Systematic review; Level of evidence, 4.
UNASSIGNED: A systematic review was performed on February 22, 2023, using the PubMed, CINAHL, MEDLINE, and Web of Science databases from database inception until February 22, 2023, on the topic of MIS for a symptomatic os trigonum.
UNASSIGNED: Of 885 articles retrieved from an initial search, 17 articles (N = 435 patients) met full inclusion criteria. The mean age of the cohort was 26.01 ± 4.68 years, with a mean follow-up time of 34.63 ± 18.20 months. For patients treated with MIS, the mean preoperative American Orthopaedic Foot and Ankle Society (AOFAS) score was 55.85 ± 12.75, the mean final postoperative AOFAS score was 94.88 ± 4.04, the mean preoperative visual analog scale pain score was 7.20 ± 0.43, and the mean final postoperative visual analog scale score was 0.71 ± 0.48. The mean time to return to sport for patients undergoing MIS was 7.76 ± 1.42 weeks. MIS had an overall complication rate of 5.0%, the majority of which consisted of transient neurapraxia of the sural or superficial peroneal nerve.
UNASSIGNED: Minimally invasive management of a symptomatic os trigonum appears to be a viable alternative to open surgery in terms of outcomes, return to sport, and complication rates. More high-quality evidence will be required to definitely recommend minimally invasive approaches as the standard of care over open surgery.
UNASSIGNED: To examine patient outcomes, return to sport, and complications associated with MIS for a symptomatic os trigonum.
UNASSIGNED: Systematic review; Level of evidence, 4.
UNASSIGNED: A systematic review was performed on February 22, 2023, using the PubMed, CINAHL, MEDLINE, and Web of Science databases from database inception until February 22, 2023, on the topic of MIS for a symptomatic os trigonum.
UNASSIGNED: Of 885 articles retrieved from an initial search, 17 articles (N = 435 patients) met full inclusion criteria. The mean age of the cohort was 26.01 ± 4.68 years, with a mean follow-up time of 34.63 ± 18.20 months. For patients treated with MIS, the mean preoperative American Orthopaedic Foot and Ankle Society (AOFAS) score was 55.85 ± 12.75, the mean final postoperative AOFAS score was 94.88 ± 4.04, the mean preoperative visual analog scale pain score was 7.20 ± 0.43, and the mean final postoperative visual analog scale score was 0.71 ± 0.48. The mean time to return to sport for patients undergoing MIS was 7.76 ± 1.42 weeks. MIS had an overall complication rate of 5.0%, the majority of which consisted of transient neurapraxia of the sural or superficial peroneal nerve.
UNASSIGNED: Minimally invasive management of a symptomatic os trigonum appears to be a viable alternative to open surgery in terms of outcomes, return to sport, and complication rates. More high-quality evidence will be required to definitely recommend minimally invasive approaches as the standard of care over open surgery.
摘要：
■有症状的三角肌是后踝关节疼痛的常见原因，传统上采用开放切除术治疗。微创手术（MIS）已被提议作为开放切除术的替代方案，以改善预后并降低并发症发生率；然而，迄今为止,还没有系统评价对有症状的三角体的MIS的使用情况进行检查.
■为了检查患者的预后，回到运动,以及与有症状的三角肌MIS相关的并发症。
■系统评价；证据水平，4.
■于2023年2月22日使用PubMed进行了系统评价，CINAHL,MEDLINE,从数据库开始到2023年2月22日，以及WebofScience数据库，主题是症状性三角蛋白的MIS。
■在从初始搜索中检索到的885篇文章中，17篇文章（N=435例患者）符合完全纳入标准。该队列的平均年龄为26.01±4.68岁，平均随访时间34.63±18.20个月。对于接受MIS治疗的患者，术前美国骨科足踝协会(AOFAS)平均得分为55.85±12.75分,术后最终AOFAS平均得分为94.88±4.04分,术前视觉模拟量表疼痛平均得分为7.20±0.43分,术后最终视觉模拟量表平均得分为0.71±0.48分.MIS患者恢复运动的平均时间为7.76±1.42周。MIS总体并发症发生率为5.0%，其中大部分由腓肠或腓肠浅神经的短暂性神经失用症组成。
■就结局而言，对有症状的三角骨进行微创治疗似乎是开放手术的可行替代方法。回到运动,和并发症发生率。需要更多高质量的证据来明确推荐微创方法作为开放手术的护理标准。
■为了检查患者的预后，回到运动,以及与有症状的三角肌MIS相关的并发症。
■系统评价；证据水平，4.
■于2023年2月22日使用PubMed进行了系统评价，CINAHL,MEDLINE,从数据库开始到2023年2月22日，以及WebofScience数据库，主题是症状性三角蛋白的MIS。
■在从初始搜索中检索到的885篇文章中，17篇文章（N=435例患者）符合完全纳入标准。该队列的平均年龄为26.01±4.68岁，平均随访时间34.63±18.20个月。对于接受MIS治疗的患者，术前美国骨科足踝协会(AOFAS)平均得分为55.85±12.75分,术后最终AOFAS平均得分为94.88±4.04分,术前视觉模拟量表疼痛平均得分为7.20±0.43分,术后最终视觉模拟量表平均得分为0.71±0.48分.MIS患者恢复运动的平均时间为7.76±1.42周。MIS总体并发症发生率为5.0%，其中大部分由腓肠或腓肠浅神经的短暂性神经失用症组成。
■就结局而言，对有症状的三角骨进行微创治疗似乎是开放手术的可行替代方法。回到运动,和并发症发生率。需要更多高质量的证据来明确推荐微创方法作为开放手术的护理标准。
